Literature DB >> 17183578

The regional genetic and newborn screening service collaboratives: the first two years.

Michele Puryear1, Gloria Weissman, Michael Watson, Marie Mann, Bonnie Strickland, Peter C van Dyck.   

Abstract

Newborn screening and genetic technologies are expanding and changing rapidly, increasing the demand for genetic specialty services. Because of the scarcity and geographic maldistribution of genetic specialty services, access to these services is a critical issue. This article discusses some of the efforts initiated by the Maternal and Child Health Bureau of the Health Resources and Services Administration, particularly the establishment of regional genetic and newborn screening collaboratives to improve access to these services and expertise.

Entities:  

Mesh:

Year:  2006        PMID: 17183578     DOI: 10.1002/mrdd.20121

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  4 in total

1.  Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots.

Authors:  Erin W Rothwell; Rebecca A Anderson; Matthew J Burbank; Aaron J Goldenberg; Michelle Huckaby Lewis; Louisa A Stark; Bob Wong; Jeffrey R Botkin
Journal:  Am J Public Health       Date:  2011-02-17       Impact factor: 9.308

Review 2.  Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning.

Authors:  Bradford L Therrell; Michele A Lloyd-Puryear; Kathryn M Camp; Marie Y Mann
Journal:  Mol Genet Metab       Date:  2014-07-16       Impact factor: 4.797

3.  Structures for clinical follow-up: newborn screening.

Authors:  R Rodney Howell; Gilian Engelson
Journal:  J Inherit Metab Dis       Date:  2007-08-10       Impact factor: 4.982

4.  Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.

Authors:  Cynthia F Hinton; Cara T Mai; Sarah K Nabukera; Lorenzo D Botto; Lisa Feuchtbaum; Paul A Romitti; Ying Wang; Kimberly Noble Piper; Richard S Olney
Journal:  Genet Med       Date:  2013-12-05       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.